NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neuspera Medical

Neuspera Medical

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://neuspera.com/

Last Round

Series D

Jul 15, 2024

Total Funding Raised

$149M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neuspera Medical is a medical technology company that develops implantable neuromodulation devices aimed at enhancing the quality of life for patients with chronic illnesses through less invasive and more adaptable treatment options.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

sacral neuromodulationSNMurinary incontinencebattery-free implantintegrated sacral neuromodulationiSNMpercutaneous sacral neuromodulationpSNMminimally invasive surgeryneurostimulatormedtechfemtechimplantable medical deviceurology deviceneuromod

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuspera Medical Comparables

Compare Neuspera Medical with similar companies based on industry and business-model similarity.

Neuspera Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BlueWind Medical
90%
SacraMed
87%
Medtronic
82%

Neuspera Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 15, 2024
Series CJul 20, 2021
Series BFeb 20, 2019
Series BJan 24, 2018
Series AMay 12, 2016
Angel
May 1, 2016

Key People

Founding team and executive leadership

David Van Meter

Executive Chairman, Interim CEO, And Member Board Of Directors

Executive Team

Bunty Banerjee

Chief Operating Officer

Executive Team

Neuspera Medical Investors

Notable investors and investment history

Neuspera Medical investors
InvestorRounds
Olympus Innovation VenturesSeries D
Vertex Ventures HCSeries C, Series D
Orion Capital AsiaSeries D
Action Potential Venture CapitalSeries B, Series A, Series C, Series D
Alumni VenturesSeries B
Windham Capital PartnersSeries C, Series B, Series A, Series D
6 Dimensions CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 124% MoM.

  • Jul 20, 2021

    $65M round led by Treo Ventures and Vertex Ventures HC.

Neuspera Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuspera Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuspera Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Jose, California
Employee Range37
Year Founded2013
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.